Could a Butter-Like supplement protect the aging brain?
NCT ID NCT06797817
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tests whether a daily supplement called tributyrin can slow memory decline in people with mild Alzheimer's disease. Over 12 weeks, 156 participants will take either tributyrin or a placebo, and researchers will measure changes in thinking skills, inflammation, and gut health. The goal is to see if boosting butyrate—a substance linked to gut health—can help protect the brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universidad de Almería
Almería, Spain
Conditions
Explore the condition pages connected to this study.